Skip to main content
Stonvex
Loading…
Home
Activity
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
← Back to rankings
ANRO
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w high -19.2%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
alto
neuroscience
class
investors
action
firm
about
securities
against
lawsuit
statements
effectiveness
deadline
rosen
disorder
alleging
treating
major
depressive
drug
ANRO
Alto Neuroscience Inc.